Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T22:23:22.838Z.
Calculation as of: 2026-10-06T22:23:22.838Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80dc1f4e8b31b1f0ec5b4a1e5c631a71efe14c3ee5142d993ef0c896d26e8132
EARNINGS YIELD
N/A
Market Cap
$127.29M
Earnings Yield
N/A
TTM Avg
0.12%
3Y Avg
0.11%
5Y Avg
0.11%
Market Cap
$131.21M
Earnings Yield
N/A
TTM Avg
0.52%
3Y Avg
2.38%
5Y Avg
2.38%
Market Cap
$122.66M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $127.98M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | N/A | 0.12% | 0.11% | 0.11% |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | N/A | 0.52% | 2.38% | 2.38% |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | N/A | 60.17% | 53.61% | 53.61% |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | N/A | 5.34% | 5.34% | 5.34% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $122.43M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
